These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9310928)

  • 1. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases.
    Luo KX; Zhu YF; Zhang LX; He HT; Wang XS; Zhang L
    J Viral Hepat; 1997 Sep; 4(5):303-7. PubMed ID: 9310928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical study of Fas ligand in liver tissue of chronic hepatitis B virus infection].
    Hu J; Zhang L; Wang H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):64-6. PubMed ID: 12515176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The localization of FasL mRNA in liver tissues of chronic hepatitis B].
    Hu J; Zhang L; Zhao J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):316-7. PubMed ID: 12526342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of Fas/FasL system in induction of hepatocyte apoptosis in chronic viral hepatitides].
    Dmitrieva EV; Moskaleva EIu; Kogan EA; Bueverov AO; Belushkina NN; Ivashkin VT; Severin ES; Pal'tsev MA
    Arkh Patol; 2003; 65(6):13-7. PubMed ID: 14964961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on expression of Fas/FasL and HBV antigens in liver tissue of patients with hepatitis B].
    Wang H; Hu J; Zhu K
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):12-5. PubMed ID: 12526294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis and Fas system are significantly involved in the process of liver cirrhosis converting into hepatocellular carcinoma.
    Peng Z; Tang H; Ling Y; Han G
    J Tongji Med Univ; 2001; 21(2):126-9, 148. PubMed ID: 11523216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
    Fukuzawa Y; Takahashi K; Furuta K; Tagaya T; Ishikawa T; Wada K; Omoto Y; Koji T; Kakumu S
    J Gastroenterol; 2001 Oct; 36(10):681-8. PubMed ID: 11686478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of Fas and Fas ligand in liver tissue infected with hepatitis B virus].
    Lang Z; Wang H; Meng X
    Zhonghua Nei Ke Za Zhi; 1997 Oct; 36(10):655-7. PubMed ID: 10436977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis.
    Hayashi N; Mita E
    J Viral Hepat; 1999 Sep; 6(5):357-65. PubMed ID: 10607251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis-related proteins, BCL-2, BAX, FAS, FAS-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infection.
    Ehrmann J; Galuszková D; Ehrmann J; Krc I; Jezdinská V; Vojtések B; Murray PG; Koláo Z
    Pathol Oncol Res; 2000; 6(2):130-5. PubMed ID: 10936789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fas and fas ligand pathways in liver allograft tolerance.
    Pan TL; Goto S; Lin YC; Lord R; Chiang KC; Lai CY; Chen YS; Eng HL; Cheng YF; Tatsuma T; Kitano S; Lin CL; Chen CL
    Clin Exp Immunol; 1999 Oct; 118(1):180-7. PubMed ID: 10540176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.
    Wang XZ; Chen XC; Chen YX; Zhang LJ; Li D; Chen FL; Chen ZX; Chen HY; Tao QM
    World J Gastroenterol; 2003 Dec; 9(12):2671-5. PubMed ID: 14669310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
    Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
    Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fas expression and DNA impairment of hepatocyte in chronic hepatitis B].
    Luo K; He H; Zhu Y
    Zhonghua Nei Ke Za Zhi; 1996 Nov; 35(11):750-2. PubMed ID: 9592343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and negative consequences of Fas/Fas ligand interactions in the antitumor response.
    Abrams SI
    Front Biosci; 2005 Jan; 10():809-21. PubMed ID: 15569621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of Fas (CD95) and FasL (CD95L) immunohistochemical expression suggests Fas/FasL-mediated apoptotic signal is not relevant in cutaneous Kaposi's sarcoma lesions.
    Fernández-Figueras MT; Armengol P; Puig L; Molinero JL; Esquius M; Sirera G; Ariza A
    J Cutan Pathol; 1999 Oct; 26(9):417-23. PubMed ID: 10563496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis.
    Wei Y; Chen K; Sharp GC; Yagita H; Braley-Mullen H
    J Immunol; 2001 Dec; 167(11):6678-86. PubMed ID: 11714840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on Fas/Fas-L expression in liver tissue and hepatocyte apoptosis in patients with hepatitis gravis.
    Xia Q; Shi S
    J Tongji Med Univ; 2001; 21(2):112-4. PubMed ID: 11523212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas (APO-1/CD95) ligand and Fas expression in renal cell carcinomas: correlation with the prognostic factors.
    Kim YS; Kim KH; Choi JA; Lee JH; Kim HK; Won NH; Kim I
    Arch Pathol Lab Med; 2000 May; 124(5):687-93. PubMed ID: 10782148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.